Safety and Preliminary Efficacy of Intranasal Insulin for Cognitive Impairment in Parkinson Disease and Multiple System Atrophy 1.0

File: <base>/References/Litvan-I_Diagnostic-criteria-for-mild-cognitive-impairment-in-Parkinsons-disease-Movement-Disorder-Society-Task-Force-guidelines.pdf (796,193 bytes)